RxDoctor Payments Data

Elizabeth Rajan, MD

Gastroenterology · Rochester, MNNPI 1700866993

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,680 of the $5,581 with a category attached, or 83.9%. Olympus Corporation accounts for 78.3% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $2,257 and has fallen 63.5% since, to $825 in 2023.

$5,581in general payments, 2019–2025

Across 7 payments — averaging $797.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation$4K
  • Olympus Corporation Of The Americas$923
  • Fujifilm Healthcare Americas Corporation$210
  • Boston Scientific$77
$290,657in research payments, 2019–2025

Across 30 payments — averaging $9688.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Capsovision, Inc.$282K
  • Olympus Corporation Of The Americas$8K

What the payments were for

  • Consulting fees$4,68084%
  • Speaking & faculty fees$61511%
  • Food & beverage$2865%

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,581 in reported general payments places this provider in the 80th percentile of 365 gastroenterology providers in Minnesota.

See all gastroenterology providers in Minnesota

Medicare billing

Part B allowed, 2024
$73,986
Medicare patients
355
Services billed
495

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →